2 min read

UBC Cited in Publication for Smallpox Vaccine Safety Surveillance Study

The prospective study included the enrollment 20,136 active-duty military subjects.
"Learn more about this prospective study including the enrollment of 20,136 subjects who were active-duty military personnel.

UBC is pleased to be cited in a recent publication of a smallpox vaccine study in the journal entitled, Vaccine

UBC recently participated in a smallpox safety surveillance study. This prospective study included the enrollment of 20,136 subjects who were active-duty military personnel undergoing pre-deployment medical readiness. The trial was initiated to address safety concerns relating to myopericarditis.

Vaccine is the official journal of The Edward Jenner Society and The Japanese Society for Vaccinology. The literature article was published here on September 13, 2020, with contributions from the Naval Health Research Center, Sanofi Pasteur Inc, Emergent BioSolutions, the Department of Health Policy, Vanderbilt University School of Medicine, and UBC.

From conducting clinical trials to meeting post-approval regulatory requirements, we can help guide your infectious disease product or vaccine on its critical path to rapid approval and beyond. UBC’s leadership team have authored and supported countless submissions to regulatory authorities and remain current on the latest global regulatory trends and changes. To learn more about our experience and to discuss how we can support your clinical development, head here.

D. J. Faix, D. M. Gordon, L. N. Perry et al., Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel, Vaccine, https://doi.org/10.1016/j.vaccine.2020.09.037

Other Recent Posts

Press
5 min read

UBC Announces Partnership with Osmind to Advance the Future of Mental Health Treatment and Research within REMS

First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes
Press
5 min read

UBC and Thread Expand SitePlus Offering and Active Studies with BioPharma Sponsors to Optimize Evidence Generation

This augments the central site model with additional research services and tech to widen recruitment and improves site and patient experience.
Press
1 min read

UBC Listed as a Citeline Awards Finalist for Excellence in RWE

UBC is once again a finalist for the Citeline Awards, with our 2024 nomination coming in the Excellence in RWE category.